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Significance of this study
What is already known on this subject?
 ► In chronic HBV infection, natural killer (NK) cells
show a functional impairment with defects in
their antiviral function, and the insufficiency of
T cell immunity has been clearly demonstrated.
 ► The cell subsets with suppressive features have
been recognised among monocytes and NK
cells.
What are the new findings?
 ► HBV employs hepatitis B surface antigen to
induce suppressive monocytes with HLA-E, PD-
L1, interleukin (IL)-10 and TGF-β expression via
the MyD88/NFκB signalling pathway.
 ► HBV-induced monocytes educate NK cells to
secrete IL-10.
 ► HBV-induced IL-10 producing NK cells through
monocytes is mediated by PD-L1/PD-1 and 
HLA-E/CD94.
 ► HBV-induced regulatory NK (NK-reg) cells
inhibit autologous T cell activation.
How might it impact on clinical practice in the 
foreseeable future?
 ► It contributes to better understand the
immunopathogenesis of how HBV evades
immunity and maintains persistent infection. 
Future investigation needs to address how to
manipulate the function of these NK-reg cells in
the clinical setting.
AbSTrACT
background and aims HBV infection represents 
a major health problem worldwide, but the 
immunological mechanisms by which HBV causes 
chronic persistent infection remain only partly 
understood. recently, cell subsets with suppressive 
features have been recognised among monocytes and 
natural killer (nK) cells. Here we examine the effects of 
HBV on monocytes and nK cells.
Methods Monocytes and nK cells derived from chronic 
HBV-infected patients and healthy controls were purified 
and characterised for phenotype, gene expression and 
cytokines secretion by flow cytometry, quantitative 
real-time (qrt)-Pcr, eliSa and western blotting. culture 
and coculture of monocytes and nK cells were used to 
determine nK cell activation, using intracellular cytokines 
staining.
results in chronic HBV infection, monocytes express 
higher levels of PD-l1, Hla-e, interleukin (il)-10 and 
tgF-β, and nK cells express higher levels of PD-1, 
cD94 and il-10, compared with healthy individuals. 
HBV employs hepatitis B surface antigen (HBsag) to 
induce suppressive monocytes with Hla-e, PD-l1, il-10 
and tgF-β expression via the MyD88/nFκB signalling 
pathway. HBV-treated monocytes induce nK cells to 
produce il-10, via PD-l1 and Hla-e signals. Such nK 
cells inhibit autologous t cell activation.
Conclusions Our findings reveal an immunosuppressive 
cascade, in which HBV generates suppressive monocytes, 
which initiate regulatory nK cells differentiation resulting 
in t cell inhibition.
HBV infection represents a major health problem 
worldwide. Over 240 million individuals are chron-
ically infected with HBV and are at high risk of 
developing liver cirrhosis and hepatocellular carci-
noma.1 Chronic HBV infection (CHB) occurs as a 
result of an ineffective antiviral immune response.2 
Although the insufficiency of T cell immunity in HBV 
persistent infection has been clearly demonstrated, 
the role of innate immune cells involving mono-
cytes and natural killer (NK) cells still remains to be 
clarified.
The innate immune system provides the first 
line of defence in antiviral responses and acti-
vates adaptive immune responses.3 Monocytes 
are innate immune cells and play multiple roles in 
immune function.4 5 Hepatitis B surface antigen 
(HBsAg) is the most abundant HBV protein in the 
liver and peripheral blood of patients with CHB.6 
High concentration of HBsAg in the bloodstream 
of patients with CHB could theoretically contribute 
to the impaired immune response. Several studies 
have shown that HBsAg can suppress the release 
of c-induced cytokines by interfering with the Toll-
like receptor (TLR) signal pathway in monocytes/
macrophages, which may contribute to the estab-
lishment of chronic infections.7 8
NK cells are another important component of 
the innate immune system,9 which respond very 
rapidly to virus-infected or transformed cells and 
kill virus-infected or malignant transformed cells 
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without presensitisation and restriction by major histocom-
patibility antigen.10 NK cells play key roles in innate antiviral 
immunity and have important functions that shape and influence 
adaptive immune responses and play immunoregulatory roles.11 
Human interleukin (IL)-10-producing regulatory NK cells were 
showed to express low transforming growth factor (TGF)-β 
and IL-13 but no Interferon-γ (IFN-γ).12 In patients with breast 
cancer, circulating NK cells include rare cells producing TGF-β 
and IL-10, which exert a suppressive influence on innate and 
adaptive immunity.13 In CHB, NK cells show a functional 
impairment with defects in their antiviral function,14 15 but the 
mechanism is only partly understood. The immunosuppressive 
cytokine environment in CHB, created through high levels of 
IL-10, may inhibit the ability of NK cells to produce IFN-γ,16 
as has already been shown in acutely infected patients.17 This 
defect persists in patients with CHB receiving antiviral therapy 
but can be reversed in vitro by specific blockade of IL-10 and 
TGF-β.18
NK cell activation can be triggered by the interaction of the 
receptor 2B4 with the ligand CD48 present on the surface of 
peripheral blood mononuclear cell (PBMC)-derived macro-
phages.19 Blockade of NKp46 and DNAX accessory molecule-1 
decreases NK cell cytotoxicity against cytomegalovirus-infected 
macrophages and lipopolysaccharides (LPS)-stimulated macro-
phages derived from PBMC.20 Monocytes activated by TLR 
increase the expression of activation-induced C-type lectin 
(AICL), which is the ligand of the NK cell activating receptor 
NKp80, the interaction AICL–NKp80 induces IFN-γ production 
of NK cells.21 More recently, the secretion of IL-12 by CpG DNA 
or Bacillus anthracis-infected macrophages enhances the release 
of IFN-γ by mouse NK cells but depends on cell-to-cell contact.22
In the present study, we found that compared with cells 
from normal donors, both monocytes and NK cells derived 
from the chronic HBV-infected patients display suppres-
sive characteristics. We thus hypothesised that HBV induces 
suppressive monocytes to educate NK cells differentiating 
into IL-10+ regulatory NK cells. Our findings provide a novel 
mechanism by which HBV initiates an immunosuppressive 
cascade involving monocytes, NK cells and T cells; it may 




Thirty-five treatment-naive patients with CHB and 35 healthy 
individuals were enrolled in this study (online supplemen-
tary table 1). These studies were approved by the IRB of 
Jilin University, The First Hospital (No: 2015215). Written 
informed consent was obtained from all adult participants, 
and no children were involved in this study. All experiments 
were carried out in accordance with the approved guidelines 
and regulations.
reagents
HBsAg was purchased from Meridian (Memphis, Tennessee, USA, 
Catalogue #: R36100), which is purified from human plasma with 
the purification >95%. ST2825 and BAY 11–7082 were purchased 
from Medchem Express (Monmouth Junction, New Jersey, USA). . 
These Abs, rabbit monoclonal anti-IκB-α, mouse monoclonal anti-
phospho-IκB-α, anti-MyD88 and anti-β-actin, were detected using 
HRP-conjugated goat or rabbit anti-mouse secondary Abs. All of 
these Abs were purchased from CST.
limulus amoebocyte assay for lPS contamination
Endotoxic contamination of HBsAg was assessed using 
QCL-1000 chromogenic end point assay (Combrex, Cotton-
wood, Arizona, USA) and found to be less than 1 pg/mL.
Cell culture of HbV (HbVcc)
HepG2.2.15 cells were cultured in tetracycline-free medium 
to induce virion production; supernatant was collected every 
other day with culture medium replenishment for 18 days. The 
pooled supernatant was mixed with polyethylene glycol-8000 
powder (final concentration of 10%) and gently rotated at 4°C 
overnight. HBV particles were then precipitated by centrifuga-
tion at 1000 g for 30 min at 4°C and redissolved in serum-free 
DMEM/F12 medium with 1% vol of the original supernatant 
samples. The concentrated virus stocks were aliquoted and 
stored at −80°C.
Cell isolation and purification
PBMCs were freshly isolated from peripheral blood of healthy 
individuals and patients with CHB by ficoll density gradient sepa-
ration. Monocytes and NK cells were then purified by magnetic 
cell sorting with CD14+ microbeads and NK cell isolation kit 
(Miltenyi Biotec). The purity of cells was equal or greater than 
95% as determined by flow cytometry.
Cell culture of monocytes and nK cells
Purified monocytes from healthy HBV-negative and HCV-nega-
tive blood donors were cultured with HBVcc or HBsAg, which 
concentrations are given in the figure legends. To compare the 
function of monocytes and NK cells between healthy individuals 
and patients with CHB, monocytes were stimulated with LPS 
(1 µg/mL) and NK cells by PHA (10 µg/mL) for 16 hours. Cells 
and supernatants were collected for the detection of phenotype, 
signalling molecules and cytokines.
Generation of dendritic cells (dCs)
DCs were generated from monocytes with GM-CSF and IL-4 for 
5 days following LPS stimulation for another 2 days.
Cell coculture
Purified NK cells and monocytes were cocultured for 16 hours 
at a 1:1 ratio in complete medium in presence or absence of 
HBsAg and HBVcc. Brefeldin A (Sigma-Aldrich) was subse-
quently added at a final concentration of 5 µg/mL. NK cells 
were stained for intracellular expression of IL-10 and IFN-γ. 
Mouse IgG was used as an isotype-matched control anti-
body. To investigate the contact dependence of the interac-
tion, monocytes and NK cells were separated by a membrane 
(0.4 µm pore size) in transwell plates (Costar, Corning). To 
investigate the involvement of selected molecules, blocking 
experiments were performed by adding the following mAbs: 
α-TGF-β, α-IL-10, α-TNF-α, α-PD-L1, α-PD-1, α-HLA-E and 
α-CD94. Control experiments were performed using isotype-
matched mouse antibodies (all mAbs from R&D Systems). All 
mAbs were used at a final concentration of 10 µg/mL.
For the regulatory effect of NK cells on non-specific T cell 
activation, purified T cells were cocultured with autologous 
NK cells, which were repurified from monocyte/NK cell cocul-
ture with or without HBsAg/HBVcc and stimulated with PHA 
in the presence or absence of anti-IL-10 antibody. For the 
regulatory effect of NK cells on HBV-specific T cell response, 
monocytes, NK cells and T cells were purified from patients 
with CHB. T cells were cocultured with autologous DCs 
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Figure 1 Phenotypic and functional difference of monocytes between chronic HBV-infected patients and HCs. Peripheral blood mononuclear cells 
(PBMCs) were isolated from health individuals (n=35) and chronic hepatitis B patients (n=35). CD14 staining was used to identify monocytes. (A) The 
gating strategies of monocytes from PBMCs. (B) The expression levels of HLA-E and PD-L1 on monocytes from chronic HBV-infected patients and HCs 
were analysed by flow cytometry. (C) TNF-α, TGF-β and IL-10 mRNA expression of pure monocytes were determined by qRT-PCR. (D and E) Monocytes 
from patients with CHB and HCs were purified and stimulated with LPS for 16 hours. The expression and secretion of TNF-α, TGF-β and IL-10 were 
detected by intracellular cytokine staining and ELISA, respectively. A representative experiment from 35 independent experiments is shown. The error 
bars represent SEM. *p<0.05. CD14, Cluster of Differentiation 14; CHB, chronic HBV infection; FSC, forward scatter; HCs, healthy controls; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; IL, interleukin; qRT-MFI, mean fluorescence intensity; PCR, quantitative real-time PCR; SSC, side scatter; 
TGF-β, transforming growth factor-β.
loaded with either HBsAg or hepatitis E virus open reading 
frame 2 (HEV-ORF2) protein in the presence of NK cells, 
which were repurified from monocyte/NK cell coculture with 
or without HBsAg/HBVcc.
Flow cytometry
Freshly isolated PBMCs or cultured monocytes and/or NK cells 
were resuspended in staining buffer and preincubated with FcR 
blocking reagent (Miltenyi Biotec) for 15 min at 4°C. Monocytes 
were stained with V450 Mouse Anti-Human CD14, PE-Cy7 
Mouse Anti-Human PD-L1, PE Mouse Anti-Human HLA-E, NK 
cells stained with APC Mouse Anti-Human CD3, PE Mouse Anti-
Human CD56, APC Mouse Anti-Human CD94 and FITC Mouse 
Anti-Human PD-1. Cells for detection of intracellular cytokines 
expression were operated by methods as above. TNF-α, TGF-β and 
IL-10 were used in monocytes, and IFN-γ IL-10 were used in NK 
cells. All the antibodies were obtained from BD Biosciences. BD 
LSRII Fortesa instrument was used to perform experiments, and 
the data acquired were analysed with FlowJo (Treestar software, 
Ashland, Oregon, USA).
T cell proliferation assay
T cell proliferation was performed as described previously.23 
Briefly, before cocultured with autologous DCs and/or NK 
cells, T cells were labelled with 5 mM CFSE (Molecular Probes, 
Grand Island, New York, USA) according to the manufactur-
er’s recommended protocol. After cocultured for 5 days, when 
clumps were visible, cells were harvested and assessed the 
proliferation of CD4+ and CD8+ T cells by flow cytometry.
enzyme-linked immunosorbent assay
The cell culture supernatants were collected after 2 days incu-
bation in each experimental condition. The concentration 
of TNF-α, IL-10, TGF-β and IFN-γ were measured by ELISA 
according to the manufacturer’s instructions.
Quantitative real-time PCr (qrT-PCr)
qRT-PCR analysis was performed using standard proce-
dures. RNA extraction, cDNA transcript and real-time PCR 
experiment were performed according to the manufacturer’s 
instructions. The sequences of gene-specific and GAPDH 
primers used for quantitative real-time PCR are listed in 
online supplementary table 2.
Western blotting analysis
Pure monocytes were incubated with 10 µg/mL HBsAg or in the 
presence of HBsAb, after 3 hours of stimulation, cells were collected 
and lysed for western blotting analysis as described previously.23
Statistical analysis
Statistics were performed using Prism statistical software 
(GraphPad). All analyses were unpaired, one-way, non-para-
metric Mann-Whitney U tests.
reSulTS
Phenotypic and functional comparison of monocytes and nK 
cells between patients with CHb and healthy controls
We compared the phenotypic and functional difference of mono-
cytes and NK cells between the patients with CHB and healthy 
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Figure 2 Phenotypic and functional difference of NK cells between chronic HBV-infected patients and HCs. PBMCs were isolated from health 
individuals and patients with chronic hepatitis B. CD3 and CD56 were used for identify NK cells. (A) The gating strategies of NK cells from PBMCs. 
(B) The expression levels of PD-1 and CD94 on NK cells were analysed by flow cytometry. (C) NK cells were purified, and messenger RNA expression
levels of TGF-β, IL-10, IL-12, IL-18 and T-bet were determined by qRT-PCR. (D and E) NK cells from chronic HBV-infected patients and HCs were
purified and stimulated with PHA for 16 hours. The expression and secretion of IL-10 were detected by intracellular cytokine staining and ELISA, 
respectively. A representative experiment from 35 independent experiments is shown. The error bars represent SEM. *p<0.05. CD94, cluster of
differentiation 94; CHB, chronic HBV infection; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HCs, healthy controls; IL, interleukin; MFI, mean
fluorescence intensity; NK, natural killer; PBMCs, peripheral blood mononuclear cells; PD-1, programmed death1-ligand; qRT-PCR, quantitative real-
time PCR; TGF-β, transforming growth factor-β.
controls. The gating strategies of monocytes and NK cells from 
PBMCs were showed in figures 1A and 2A; we observed that 
the expression levels of PD-L1 and HLA-E on monocytes from 
patients with CHB are much higher than that of healthy controls 
(figure 1B, p<0.05). The expression levels of PD-1 and CD94 
on NK cells from patients with CHB are significantly higher 
than healthy controls (figure 2B, p<0.05). The mRNA expres-
sion levels of TNF-α, TGF-β and IL-10 are significantly higher in 
pure monocytes from patients with CHB than that of in healthy 
donors (figure 1C, p<0.05). Compared with healthy individuals, 
the expression levels of TGF-β and IL-10 were much higher, and 
the expression levels of IL-12, IL-18 and T-bet were much lower 
in pure NK cells from the patients with CHB (figure 2C, p<0.05).
Pure monocytes from the patients with CHB and healthy 
controls were stimulated with LPS for 16 hours. Intracellular and 
secreted TNF-α, TGF-β and IL-10 were detected by staining (IC) 
and ELISA, respectively. The results were shown in figure 1D,E. 
Monocytes from patients with CHB expressed and secreted much 
more TNF-α, IL-10 and TGF-β, compared with healthy controls 
(p<0.05). Pure NK cells from patients with CHB and healthy 
controls were stimulated with PHA. IL-10 synthesis and secretion 
of NK cells were detected by IC staining and ELISA, respectively 
(figure 2D,E). NK cells from patients with CHB expressed and 
secreted much more IL-10 than healthy controls (p<0.05). Taken 
together, these results suggested that monocytes and NK cells 
derived from patients with CHB display suppressive characteristics.
HbV employs HbsAg to induce immunosuppressive monocytes
The immunosuppressive effects of HBV or the encoded proteins, 
HBeAg and HBsAg, have been documented previously.24–26 In 
order to test whether HBV induces suppressive monocytes, pure 
monocytes from healthy donors were cultured with increasing 
concentrations of HBsAg (0.1, 1.0 and 10 µg/mL) or HBVcc 
(105, 106, 107 copies/mL). HLA-E and PD-L1 expression on 
monocytes were analysed by flow cytometry. As expected, both 
HBsAg and HBVcc caused a dose-dependent increase expres-
sion of HLA-E (figure 3A) and PD-L1 (figure 3B). Both HBsAg 
and HBVcc induced a dose-dependent increase in secretion of 
TNF-α (figure 3C), IL-10 (figure 3D) and TGF-β (figure 3E). 107 
copies/mL of HBVcc and 10 µg/mL HBsAg were used in most 
experiments. We also observed that neutralisation of HBsAg by 
HBsAb inhibits HBsAg-induced and HBVcc-induced PD-L1 and 
HLA-E expression (figure 3F,G, p<0.05), and TNF-α, IL-10 and 
TGF-β productions (figure 3H, p<0.05), but hepatitis B early 
antigen (HBeAg) and HBcAg antibody could not neutralise the 
HBV-induced monocytes suppressive phenotype and cytokines 
production in online supplementary figure 1. These results indi-
cate that HBV employs HBsAg to induce monocytes to express 
both inflammatory cytokines and immunosuppressive molecules.
HbsAg induced immunosuppressive monocytes via the 
Myd88/nFκb pathway
We next investigated how HBsAg induces immunosuppres-
sive monocytes. The results of qRT-PCR showed that HBsAg 
increases the mRNA expression levels of MyD88 and NFκB, 
compared with medium control (figure 4A, p<0.05). The results 
of western blotting were shown in figure 4B, HBsAg significantly 
increased IκB-α phosphorylation (p<0.05) and MyD88 expres-
sion (p<0.05). The neutralisation of HBsAg by HBsAb inhibited 
HBsAg-induced mRNA expression of MyD88 and NFκB, as well 
as iκB-α phosphorylation and MyD88 expression. ST2825 and 
BAY 11–7082 were used as inhibitors of MyD88 and NFκB,27 28 
respectively. To further test whether HBsAg induced immuno-
suppressive monocytes via MyD88 and NFκB signalling, ST2825 
and BAY 11–7082 were added to monocytes cultured with 
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Figure 3 Exposure to HBsAg and HBVcc, monocytes display suppressive phenotypes. Purified monocytes from healthy donors (n=5) were stimulated 
with HBVcc or HBsAg for 24 hours. Cells and the supernatants were collected for FACS and cytokines detection. (A and B) HBsAg and HBVcc induce a 
dose-dependent increase expression of PD-L1 and HLA-E. (C–E) HBsAg and HBVcc induce a dose-dependent increase secretion of TNF-α, TGF-β and 
IL-10. (F and G) Neutralisation of HBsAb inhibits HBsAg-induced and HBVcc-induced the expression of PD-L1 and HLA-E and cytokine production. 
A representative experiment from five independent experiments is shown. The error bars represent SEM. *p<0.05. FACS, fluorescence activated cell 
sorter; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; HBVcc, cell culture of HBV; HLA-E, human leukocyte antigen-E; IL, 
interleukin;  MFI, mean fluorescence intensity; PD-L1, programmed death1-ligand; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-
alpha.
HBsAg. We observed that the inhibitors of MyD88 and NFκB 
suppressed the expression levels of HBV-induced PD-L1 and 
HLA-E (figure 4C, p<0.05). Using ELISA we also found that the 
inhibitors of MyD88 and NFκB suppressed the secretion levels 
of HBV-induced TNF-α, IL-10 and TGF-β (figure 4D, p<0.05).
HbV-induced monocytes educate nK cells to secrete il-10
To further investigate HBV-induced monocytes interactions with 
NK cells, freshly isolated human PBMCs, PBMCs depleted of 
CD14+ cells, pure NK cells and monocytes were cultured or cocul-
tured with HBsAg or HBVcc. Cells were stained with CD3 and 
CD56 for NK cell gating, and IL-10 and IFN-γ expression levels of 
NK cells were determined by intracellular cytokines staining. The 
effects of the HBsAg or HBVcc on IL-10 and IFN-γ expression by 
NK cells are represented in figure 5A, and the statistics were anal-
ysed and shown in figure 5B. The IFN-γ and IL-10 expression 
of NK cells from monocytes-depleted PBMCs were significantly 
lower than that of NK cells from PBMCs (p<0.05). Pure NK cells 
failed to respond to both HBsAg and HBVcc, and NK cells cocul-
tured with monocytes responded to HBsAg and HBVcc, expressed 
much higher level of IL-10 (9.5%±1.3% vs 2.8±1.1%, p<0.05) 
and a lower level of IFN-γ (3.8%±0.8% vs 6.3±1.0%, p<0.05) 
than that of separated NK cells and monocytes cocultures in a tran-
swell. These results indicate that both HBsAg and HBVcc induce 
IFN-γ expression of NK cells and regulatory NK cells (NK-reg) cell 
differentiation manifested as induced IL-10 expression but that this 
effect requires monocytes. In NK cell/monocyte direct coculture, 
HBV induced NK cells to produce much more IL-10 than IFN-γ. 
However, when NK cells and monocytes were cocultured in a tran-
swell, HBV induced NK cells to produce more IFN-γ than IL-10. 
This argues that different signals are mediated by direct contact 
and cytokines, such that cell contact was responsible for NK cells 
producing IL-10, while cytokine signals promoted NK cells to 
produce IFN-γ.
HbV-induced il-10 producing nK cells through monocytes is 
mediated by Pd-l1/Pd-1 and HlA-e/Cd94
To directly investigate the monocytes signals that educate NK 
cells to produce IL-10, antibodies of PD-L1, PD-1, HLA-E, 
CD94, IL-10, TNF-α and TGF-β were added to monocyte/
NK cell cocultures. A representative experiment was shown in 
figure 6A, and the statistical analysis was shown in figure 6B. 
We observed that the blockade of PD-L1/PD-1 and HLA-E/
CD94 significantly inhibited the IL-10 expression of NK cells 
but increased the IFN-γ expression of NK cells (p<0.05). The 
neutralisation of IL-10, TNF-α and TGF-β had no significant 
effect on NK cell activation (online supplementary figure 2, 
p>0.05). These results suggest that HBV-induced PD-L1, HLA-E 
on monocytes was interacting with their ligands PD-1 and CD94
on NK cells to educate IL-10+ regulatory NK cell differentiation.
HbV-induced nK-reg cells inhibit autologous Cd4+ and Cd8+ T 
cell activation via il-10
We next investigated whether HBV-induced NK-reg cells inhib-
ited T cell activation. The CFSE-labelled autologous T cells 
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Figure 4 HBsAg induce the suppressive monocytes via MyD88/NFκB pathway. Purified monocytes from healthy donors (n=10) were stimulated 
with HBsAg for 16 hours. (A) HBsAg-induced messenger RNA expression of MyD88 and NFκB were determined by qRT-PCR. (B) HBsAg-induced 
MyD88 and NFκB expression were detected by western blotting. (C) BAY 11-7082 (NFκB inhibitor) and ST2825 (MYD88 inhibitor) inhibit HBsAg-
induced HLA-E and PD-L1 expression. (D) BAY 11-7082 (NFκB inhibitor) and ST2825 (MYD88 inhibitor) inhibit HBsAg-induced cytokine production. 
The error bars represent SEM. *p<0.05. HBsAg, hepatitis B surface antigen; IL, interleukin; qRT-PCR, quantitative real-time PCR.
Figure 5 HBV-induced monocytes as educator of IL-10 producing NK cells. Freshly isolated human PBMCs, PBMCs depleted of CD14+ cells, NK 
cells and monocytes from healthy control were cultured or cocultured with HBsAg (10 μg/mL) or HBVcc (107 copies/mL) for 24 hours. NK cells were 
identified by CD3 and CD56 staining, and the expression of IL-10 and IFN-γ were examined by intracellular cytokine staining. (A) A representative 
experiment from five independent experiments is shown. (B) Statistical analysis for the expression of IL-10 and IFN-γ on NK cells. The error bars 
represent SEM. *p<0.05. HBsAg, hepatitis B surface antigen; HBVcc, cell culture of HBV; IL, interleukin; NK, natural killer; PBMCs, peripheral blood 
mononuclear cells.
were cocultured with NK cells, which were repurified from 
monocyte/NK cell coculture with or without HBsAg/HBVcc, 
and stimulated with PHA in presence or absence of anti-IL-10 
antibody. CD4+ and CD8+ T cell proliferation was examined 
by flow cytometry. The supernatants of NK/T cell cocultures 
were collected to measure IFN-γ by ELISA. We observed that 
2041li H, et al. Gut 2018;67:2035–2044. doi:10.1136/gutjnl-2017-314098
Hepatology
Figure 6 HBsAg-induced and HBVcc-induced NK-reg differentiation through monocytes is mediated by PD-L1/PD-1, HLA-E/CD94. Purified 
monocytes and NK cells were cocultured for 24 hours with HBsAg (10 μg/mL) or HBVcc (107 copies/mL) in presence of PD-L1, PD-1, HLA-E, CD94, 
IL-10, TNF-α and TGF-β antibodies. NK cells were identified by CD3 and CD56 staining, and the expression of IL-10 and IFN-γ were examined by 
intracellular cytokine staining. (A) A representative experiment from five independent experiments is shown. (B) Statistical analysis for the expression 
of IL-10 and IFN-γ on NK cells. The error bars represent SEM. *p<0.05. HBsAg, hepatitis B surface antigen; HBVcc, cell culture of HBV; IL, interleukin; 
NK, natural killer; NK-reg, regulatory NK cell; TGF-β, transforming growth factor-β.
both HBsAg-induced and HBVcc-induced NK cells via mono-
cytes significantly suppressed the proliferation of CD4+ T cells 
and CD8+ T cells (figure 7A–C, p<0.05), and IFN-γ produc-
tion (figure 7D, p<0.05), compared with control. When IL-10 
antibody was added to NK/T cells coculture, we observed that 
neutralisation of IL-10 restored the proliferation of CD4+ T cells 
and CD8+ T cell (p<0.05), as well as IFN-γ secretion (p<0.05). 
These results indicate HBV-induced monocytes programme NK 
cells to inhibit autologous CD4+ and CD8+ T cell activation in 
an IL-10 dependent manner.
To further investigate the regulatory effect of NK cells on 
HBV-specific T cell response, we purified monocytes, NK cells 
and T cells from patients with CHB patients and generated 
DCs from monocytes. T cells were cocultured with autologous 
DCs loaded with either HBsAg or HEV-ORF2 protein (nega-
tive control), and T cell proliferation and IFN-γ production 
were examined by flow cytometry and intracellular staining. We 
observed that HBsAg-loaded DCs obviously induce HBsAg-spe-
cific proliferation and IFN-γ production by CD4+ and CD8+ T 
cells. While we added the autologous NK cells, which were repu-
rified from monocyte/NK cell coculture with or without HBsAg/
HBVcc, into T cell/DCs coculture, the results showed that both 
HBsAg-induced and HBVcc-induced NK cells via monocytes 
significantly suppress HBsAg-specific proliferation (figure 7E–G, 
p<0.05) and IFN-γ production (figure 7H–J, p<0.05) by CD4+ 
and CD8+ T cells.
diSCuSSion
The course of HBV infection is complicated. Three phases of 
CHB are now widely accepted: an immune tolerant phase, an 
immune active phase and an inactive phase.29 Immune tolerance 
is a serious problem in CHB carriers, who are at high risk of devel-
oping cirrhosis and HCC later in life.30 NK cells and monocytes 
are two major components of innate immunity. HBV persistent 
infection is thought to result from inefficiencies of innate and 
adaptive immune responses. However, the roles of monocytes 
and NK cells in HBV persistent infection have not been well 
understood. In the present study, we found that monocytes from 
patients with CHB expressed higher levels of suppressive cell 
surface molecules (PD-L1 and HLA-E) and anti-inflammatory 
cytokines (IL-10 and TGF-β), compared with healthy individ-
uals. On LPS stimulation, monocytes from patients with CHB 
expressed and secreted much more TNF-α, IL-10 and TGF-β 
compared with healthy controls (figure 1). These findings suggest 
that in patients with CHB, monocytes display markers of chronic 
activation (PD-L1, HLA-E, TNF-α, IL-10 and TGF-β), consis-
tent with a role in perpetuating inflammation and/or inhibiting 
immunity. Recently, myeloid-derived suppressor cells (MDSCs) 
were initially defined as CD14+ monocytes to suppress lympho-
cyte activation. A higher percentage of monocytic MDSCs 
(mMDSCs) has been detected in the peripheral blood of patients 
with CHB.31 A correlation between the frequencies of mMDSCs 
and the level of HBsAg in the sera of patients with CHB was 
observed, and this correlation was confirmed in HBsAg-stim-
ulated human PBMCs and in HBV mouse models.32 33 Gran-
ulocytic MDSCs have also been reported to expand in CHB 
and inhibit T cell activation in a partially arginase-dependent 
manner.34
In CHB, NK cells exhibited selective defects of antiviral 
function, including a conserved or enhanced cytolytic activity 
and a diminished cytokine production that may contribute to 
both immunopathology and viral persistence.35 36 In this study, 
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Figure 7 HBV-induced NK cells via monocytes inhibit autologous CD4+ and CD8+ T cells activation in IL-10 dependent manner. NK cells repurified 
from monocytes/NK cells coculture with or without HBsAg/HBVcc were cocultured with CFSE-labelled autologous T cells and stimulated with PHA 
in presence of anti IL-10 antibody. (A–C) CD4+ and CD8+ T cell proliferation was examined by flow cytometry. (D) The supernatants of NK/T cell 
coculture were collected for IFN-γ detection by ELISA. To investigate the regulatory effect of NK cells on HBV-specific T cell response, monocytes, NK 
cells and T cells were purified from patients with CHB. T cells were cocultured with autologous DCs loaded with either HBsAg or HEV-ORF2 protein 
in the presence of NK cells, which were repurified from monocyte/NK cell coculture with or without HBsAg/HBVcc. (E–G) CD4+ and CD8+ T cell 
proliferation was examined by flow cytometry. (H–J) IFN-γ expression of CD4+ and CD8+ T cells were examined by intracellular cytokine staining. 
Shown is one of five representative experiments. The bars represent the SEM. *p<0.05. CHB, chronic HBV infection; DCs, dendritic cells; HBsAg, 
hepatitis B surface antigen; HBVcc, cell culture of HBV; HEV-ORF2, hepatitis E virus open reading frame 2; IL, interleukin; NK, natural killer.
we observed that the expression levels of CD94 and PD-1 on 
NK cells from patients with CHB were significantly higher 
than in healthy controls. CD94 is an inhibitory receptor that 
suppresses NK cell activation by engagement with HLA-E,37 
and PD-1 binding PD-L1 to induces NK cell exhaustion.38 We 
also found higher mRNA expression levels of TGF-β and IL-10, 
lower expression of IL-12, IL-18 and T-bet in NK cells from 
the patients with CHB. Furthermore, purified NK cells from 
patients with CHB express and produce more IL-10 on PHA 
stimulation, compared with healthy control (figure 2). Our 
results indicate that NK cells reduced hallmarks of the type 1 
response (less T-bet, IL-12 and IL-18 message) but increased 
RNA and protein level of IL-10. Consistent with our findings, 
it has been reported that the expression of inhibitory receptors 
such as NKG2A is elevated, while activating receptors, CD16 
and NKp30 are downregulated on NK cells in CHB, and this 
correlates with serum HBV DNA load.15 39 Active patients with 
CHB exhibited increased NKG2A expression on NK cells, and 
the NKG2A upregulation functionally inhibited NK cells, as 
NKG2A blockade markedly enhanced cytotoxicity in NK cells 
from active patients with CHB.40
The role of HBsAg in monocytes remains controversial. HBsAg 
can selectively inhibit TLR2 ligand-induced IL-12 production in 
monocytes/macrophages by blocking the JNK-MAPK pathway.6 
Others reported that HBsAg has an immunostimulatory effect 
by inducing TNF-α and IL-10 production.41 In this study, using 
monocytes from healthy donors stimulated with HBsAg or 
HBVcc in vitro, we discovered that HBV employed HBsAg to 
induce monocyte PD-L1 and HLA-E expression, and anti-in-
flammatory cytokine (IL-10 and TGF-β) secretion (figure 3). 
This result shows that the application of either HBV or HBsAg 
reproduces the effects of in vivo HBV infection, in terms of 
TNF-α, IL-10, TGF-β, HLA-E and PD-L1. We further observed 
that HBsAg increases message of NFκB and MyD88 and that 
the effect of HBsAg on monocytes is blocked by either NFκB 
or MyD88 inhibitors (figure 4). It indicates that HBsAg induces 
immunosuppressive monocytes via the MyD88/NFκB signalling 
pathway. It has been reported that HBsAg induces monocytes 
towards mMDSCs in an ERK/IL-6/STAT3 signalling-dependent 
manner.32 These findings suggest multiple signalling pathways 
are involved in the response of monocytes to HBsAg.
Activated monocytes interact with lymphocytes in part 
through cell surface molecules.42 Our previous study has 
addressed the impact of TLR signalling on the crosstalk between 
NK cells and Kupffer cells and revealed how the liver displayed 
a downregulated inflammatory response to constitutive bacterial 
elements through the secretion of IL-10 yet retains a vigorous 
response to viral challenge.43 IL-12 and TNF-α released by acti-
vated monocytes and macrophages were identified as powerful 
inducers of IFN-γ by NK cells.44 The immune regulation func-
tions of NK cells have been a focus of recent attention. With 
appropriate stimulation, human and mouse NK cells have been 
observed to produce the immune regulatory cytokine IL-10.45 In 
this study, we used a monocytes/NK cells coculture system and 
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Figure 8 Schematic outline of HBV initiates an immunosuppressive 
cascade. Consistent with the experimental data, HBV employ HBsAg 
to induce suppressive monocytes, which express inhibitory molecules 
PD-L1 and HLA-E, secreting IL-10, TNF-α and TGF-β through MyD88/
NFκB signalling. Engagement of PD-L1/PD-1 and HLA-E/CD94 educates 
IL-10-producing regulatory NK cells, which inhibit autologous NK 
cell activation, as well as CD4+ and CD8+ T cells activation in IL-10 
dependent manner. HBsAg, hepatitis B surface antigen; IL, interleukin; 
NK, natural killer; TGF-β, transforming growth factor-β.
found that HBV-induced IL-10-producing NK cells are mediated 
by monocytes in a cell–cell contact dependent manner (figure 5). 
We further identified that the critical signalling molecules of 
HBV-induced IL-10-producing NK cells are PD-L1/PD-1 and 
HLA-E/CD94 (figure 6), which are expressed on monocytes and 
NK cells, respectively. PD-L1 and PD-1 are coinhibitory mole-
cules that mediate T cell dysfunction in HBV and other chronic 
viral infections, and inhibition of this interaction restores 
T cell function.46 47 PD-L1/PD1 and HLA-E/CD94 interaction 
were also reported in the context of tumour immune escape.36 
HBV-induced pDCs and KCs alter NK cell function in CHB.48–50
NK cells act as killers towards tumour or virus-infected 
cells and as regulatory cells to affect the adaptive immune 
response.51 52 NK-reg expressing intracellular TGF-β and IL-10 
but no IFN-γ expression were first defined in a tumour escape 
study. Tumour-infiltrating NK-reg cells can mediate tumour 
immune escape or direct killing.13 Recent studies showed that 
decidual NK-reg cells can mediate maternal-fetal immune regu-
lation or vascular remodelling, while liver NK-reg cells can 
mediate immune tolerance or immune injury.53 NK-reg cells 
inhibited antigen-induced proliferation and IFN-γ production by 
T cells.54 In this study, we observed that HBV-treated monocytes 
induced IL-10 and IFN-γ expression in NK cells, and in mono-
cytes in direct coculture, blockade of PD-L1/PD-1 and HLA-E/
CD94 significantly inhibited the IL-10 expression and increased 
IFN-γ in NK cells (figures 5 and 6). The inhibition of IFN-γ 
production by IL-10+ NK-reg cells has been clarified as previous 
studies.55 NK cells have been assumed to participate in adaptive 
immune responses by an indirect mechanism that involves their 
secretion of cytokines and chemokines.56 NK cells enhance the 
function of CD4+ T cells and promote the differentiation of Th1 
cells by secreting IFN-γ.57 In the present study, we found that 
the HBV-induced NK cells via monocytes inhibit autologous T 
cell activation in IL-10 dependent manner as well as HBV-spe-
cific T cell response (figure 7), suggesting that HBV-induced 
NK-reg cells via monocytes directly inhibit the antiviral effect of 
NK cells and downregulate T cell immune response. It has been 
reported that in vitro removal of NK cells augments circulating 
CD8+ T cell responses directed against HBV but not against 
well-controlled viruses in patients with CHB.58
To the best of our knowledge, this is the first description of 
an immunosuppressive cascade in which NK-reg cells mediate 
between HBV-exposed monocytes and T cells as shown in 
figure 8. Future investigation needs to address how to manip-
ulate the function of these NK-reg cells in the clinical setting. 
Possible manipulation strategies to enhance immune responses 
may include altering NK-reg cell activity by means of monocytes 
depletion, PD-L1/PD-1 and HLA-E/CD94 blockade as well as 
blocking immunosuppressive cytokine function.
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